» Articles » PMID: 15479938

Bariatric Surgery: a Systematic Review and Meta-analysis

Overview
Journal JAMA
Specialty General Medicine
Date 2004 Oct 14
PMID 15479938
Citations 2311
Authors
Affiliations
Soon will be listed here.
Abstract

Context: About 5% of the US population is morbidly obese. This disease remains largely refractory to diet and drug therapy, but generally responds well to bariatric surgery.

Objective: To determine the impact of bariatric surgery on weight loss, operative mortality outcome, and 4 obesity comorbidities (diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea).

Data Sources And Study Selection: Electronic literature search of MEDLINE, Current Contents, and the Cochrane Library databases plus manual reference checks of all articles on bariatric surgery published in the English language between 1990 and 2003. Two levels of screening were used on 2738 citations.

Data Extraction: A total of 136 fully extracted studies, which included 91 overlapping patient populations (kin studies), were included for a total of 22,094 patients. Nineteen percent of the patients were men and 72.6% were women, with a mean age of 39 years (range, 16-64 years). Sex was not reported for 1537 patients (8%). The baseline mean body mass index for 16 944 patients was 46.9 (range, 32.3-68.8).

Data Synthesis: A random effects model was used in the meta-analysis. The mean (95% confidence interval) percentage of excess weight loss was 61.2% (58.1%-64.4%) for all patients; 47.5% (40.7%-54.2%) for patients who underwent gastric banding; 61.6% (56.7%-66.5%), gastric bypass; 68.2% (61.5%-74.8%), gastroplasty; and 70.1% (66.3%-73.9%), biliopancreatic diversion or duodenal switch. Operative mortality (< or =30 days) in the extracted studies was 0.1% for the purely restrictive procedures, 0.5% for gastric bypass, and 1.1% for biliopancreatic diversion or duodenal switch. Diabetes was completely resolved in 76.8% of patients and resolved or improved in 86.0%. Hyperlipidemia improved in 70% or more of patients. Hypertension was resolved in 61.7% of patients and resolved or improved in 78.5%. Obstructive sleep apnea was resolved in 85.7% of patients and was resolved or improved in 83.6% of patients.

Conclusions: Effective weight loss was achieved in morbidly obese patients after undergoing bariatric surgery. A substantial majority of patients with diabetes, hyperlipidemia, hypertension, and obstructive sleep apnea experienced complete resolution or improvement.

Citing Articles

Understanding the Long-Term Effects of Inverted-T-Abdominoplasty on Quality of Life: Insights from Post-Bariatric Surgery Patients.

Vater A, Fietz J, Schultze-Mosgau L, Lamby P, Gerauer K, Schmidt K Life (Basel). 2025; 15(2).

PMID: 40003623 PMC: 11856812. DOI: 10.3390/life15020214.


Editorial: Women's nutrition and bariatric surgery.

Moize V, Casas R Front Endocrinol (Lausanne). 2025; 16:1546308.

PMID: 39996057 PMC: 11848854. DOI: 10.3389/fendo.2025.1546308.


Changes in energy homeostasis, gut peptides, and gut microbiota in Emiratis with obesity after bariatric surgery.

Ali Ahmad M, Venema K, Ayoub Moubareck C, Wazz G, Mahdy T, Karavetian M PLoS One. 2025; 20(2):e0318699.

PMID: 39992945 PMC: 11849869. DOI: 10.1371/journal.pone.0318699.


Too Late for a Duodenal Switch? Safety and Effectiveness of Duodenal Switch in Patients over 60 Years Old.

Motola D, Hage K, MacDonald N, Lind R, Goncalves G, Jawad M Obes Surg. 2025; 35(3):790-798.

PMID: 39960607 DOI: 10.1007/s11695-025-07687-x.


Transcriptome atlases of rat brain regions and their adaptation to diabetes resolution following gastrectomy in the Goto-Kakizaki rat.

Brial F, Le Lay A, Rouch C, Henrion E, Bourgey M, Bourque G Mol Brain. 2025; 18(1):9.

PMID: 39920851 PMC: 11806591. DOI: 10.1186/s13041-025-01176-z.